NGS Controls & Reference Materials
Reproductive Health
SHOP PRODUCTSFertility, fertilization and pregnancy are all important components of reproductive health. An increase in the age of first time mothers globally along with an increase in infertility rates are driving many of the new initiatives in reproductive health, including testing.
Non-invasive prenatal testing (NIPT) is one of the fastest growing test methods for screening pregnancies due to its superior sensitivity when compared to serum screening methods. In addition, problems with fertility and conception are leading to an increased use of assisted reproductive technology (ART) and subsequent preimplantation genetic testing (PGT) to improve the odds of pregnancy. Once women conceive and are pregnant, the health of the fetus is monitored by a set of screening tests, in certain cases supported by invasive diagnostic tests.
LGC SeraCare Life Sciences offers a broad portfolio of patient-derived Reproductive Health reference materials for assay development, validation, and routine run QC. In addition to the patient-like Seraseq® NIPT reference standards, we also offer Seraseq® PGT-A reference standards.
Our materials are proven to expedite assay development, optimization and manufacturing
- Test and optimize the protocol
- Determine sensitivity and specificity
- Test LOD & range of fetal fractions
- Monitor manufacturing and lot quality
We help labs quickly and effectively validate, verify and train your staff
- Meet regulatory guidelines
- Develop a consistent benchmark
- Ensure that the test performance is as expected
- Validate new reagent lots or protocol changes
Labs running our samples routinely are able to rapidly detect and respond to sample failures and ensure accuracy
- Proactively monitor assay and instrument performance
- Expedite troubleshooting
- Ensure accuracy of results
- Monitor the entire process by using patient-like materials
